Isolation and characterization of high exopolysaccharide-producing Weissella confusa VP30 from young childrens feces by Jin, Hui et al.
Jin et al. Microb Cell Fact          (2019) 18:110  
https://doi.org/10.1186/s12934-019-1158-1
RESEARCH
Isolation and characterization of high 
exopolysaccharide-producing Weissella confusa 
VP30 from young children’s feces
Hui Jin1, Yunju Jeong1,2, Sang‑Ho Yoo3, Tony V. Johnston4, Seockmo Ku4*  and Geun Eog Ji1,2*
Abstract 
Background: Lactic acid bacteria (LAB) are known to have a significant ability to colonize the human intestinal tract 
and adhere to the surface of intestinal epithelial cells. Among the various lactic acid bacteria, exopolysaccharide (EPS) 
producing strains are known to provide a variety of health benefits for their hosts (e.g. anti‑inflammatory, antioxidant, 
antitumor and stress tolerant effects). Recently, EPSs and EPS‑producing lactic acid cultures have gained interest 
within the food industry and are playing important roles as biothickeners and texturizing agents due to their hydro‑
colloidal nature. In this study, 156 lactic acid bacterial strains isolated from fecal samples of healthy young children 
were screened and evaluated for active EPS‑production capability.
Results: Among the various human origin lactic acid flora isolated, Weissella confusa VP30 showed the highest EPS 
productivity and its EPS producing properties were characterized under various cultural conditions in this research. To 
document the safety of W. confusa VP30, antibiotic resistance, hemolytic, and ammonia production properties were 
evaluated in addition. No significant negative results were observed. The maximum EPS production by W. confusa 
VP30 was 59.99 ± 0.91 g/l after 48 h of cultivation in media containing 10% sucrose, far exceeding EPS production by 
other bacterial strains reported elsewhere. Based on gel permeation chromatography (GPC), the molecular weight 
of EPS produced by W. confusa VP30 was 3.8 × 106 Da. Structural analysis of the released EPS fraction by 13C and 1H 
nuclear magnetic resonance (NMR) spectroscopy revealed that W. confusa VP30 can produce dextran with glucose 
units linked with 96.5% α (1 → 6) glycosidic bonds and 3.5% α (1 → 3) branches.
Conclusion: The high EPS production capability and safety of W. confusa VP30 justify food industry consideration of 
this cell strain for further evaluation and potential industrial use.
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Introduction
Numerous LAB genera, including Carnobacterium, 
Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, 
Oenococcus, Pediococcus, Streptococcus, Tetragenococ-
cus, Vagococcus and Weissella sp. have been isolated from 
a variety of human, animal, plant and environmental 
sources and widely utilized for processed food produc-
tion [1–4]. According to recent industry analysis reports 
[5, 6], the global LAB and probiotics market is character-
ized by three applications and/or end-uses: (i) probiotics 
in foods and beverages [e.g. cereal, dry, dairy, non-dairy, 
baked food and fermented meat products], (ii) probiotic 
dietary supplements [e.g. nutraceuticals, single cell pro-
tein, specialty nutrients, infant formula], and (iii) ani-
mal feed probiotics [e.g. substitutes of antibiotic-based 
growth stimulants]. According to Global Market Insights 
[7], the US and EU markets were estimated at over USD 
1.8 billion and 630 million, respectively, in 2017. This 
three-part market of significant value is projected to 
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grow even further due to increased consumer interest 
in health and expanding consumer income. An increas-
ing number of food and feed companies are therefore 
trying to utilize LAB in their products to meet customer 
demand, improve product quality, and diversify their 
product lines [8].
Among LAB strains, human origin LAB strains have 
shown high resistance to gastric juice and bile as well as 
high survival rates in the gastrointestinal tract, due to 
their ability to adhere to the surface of intestinal epithelial 
cells [8, 9]. Multiple researchers have demonstrated the 
diverse biofunctionalities (e.g. anti-allergic effects, anti-
cancer properties, bacteriocin production, high transmis-
sion rates and high adherence ability) of human origin 
LAB and their metabolic substances through in vitro and 
in  vivo experiments [10–14]. Due to the verified safety 
and functional effects of human origin LAB, these spe-
cial LAB have been widely examined and applied to foods 
and livestock feeds as supplements, resulting in steadily 
increasing market demand [5, 6]. Therefore, the isolation 
of novel functional human origin intestinal bacteria and 
characterization of their bioactive molecules are impor-
tant for the production of new value-added products 
[8]. The screening of novel microorganisms and charac-
terization of their metabolites is regarded as the first step 
in their utilization as probiotics and drugs, as well as for 
metabolic engineering [15–17].
Among the bioactive molecules produced by LAB, 
there is growing demand for EPSs, which are used as 
biobased polymers [18]. EPS has been widely studied for 
its economic importance in food processing and benefi-
cial effects. EPS produced by LAB can act as a viscosifier 
and/or emulsifying agent and play an important role in 
the processing of yogurt, cheese, and other fermented 
foods as a stabilizer [19]. Multiple groups have reported 
that EPS from LAB has significant biofunctional proper-
ties and its functionality varies depending on structure 
and the bacterial strain which produced it. For example, 
EPS derived from Lactobacillus rhamnosus KL37 has 
been shown to suppress active arthritis by the inhibi-
tion of the production of arthritogenic antibodies [20]. 
According to London et al. [21], β-glucan enriched EPS 
from Lactobacillus paracasei NFBC 338 showed modula-
tory effects on lipid metabolism. EPS produced by Strep-
tococcus thermophilus ST10 and Weissella cibaria GA44 
exhibited physical defense functionality that strengthens 
the tight junction between human intestinal cells [22], 
and antioxidant effects [23], respectively. Despite these 
promising food applications and biofunctionalities, EPS 
is not yet widely utilized by food processors as a food 
additive, mainly due to low production rates by LAB [24]. 
Therefore, screening for novel LAB with high EPS pro-
duction rates is justified.
In this work, high EPS producing LAB strains with 
potential food processing applications were isolated 
from young children’s fecal samples and characterized. 
One hundred fifty-six human origin LAB strains were 
screened. All 156 LAB samples were inoculated and cul-
tured in seven modified  de Man, Rogosa, and Sharpe 
(MRS) agar (Becton, Dickinson, and Company) medias, 
each with a different carbon source. The amount of EPS 
produced from each of the 1248 different groups was 
qualitatively and/or quantitatively analyzed. Based on 
our results, the highest EPS-producing LAB (Weissella 
confusa VP30) and its key carbon source (sucrose) for 
high EPS production were determined. Further struc-
tural characterization using NMR analysis allowed us 
to elucidate the conformation of EPS from W. confusa 
VP30. This strain is also safe to use as an edible LAB 
from a food safety standpoint, according to our previous 
research [25].
Materials and methods
Sampling and isolation of LAB from young children’s feces
Using a study protocol approved by the Seoul National 
University Institutional Review Board (IRB No. 
1702/002-013), fresh fecal samples were collected from 
five young children between 1 and 6  years old for this 
study. The fecal samples were transported to the labo-
ratory at 4  °C for LAB isolation in a laminar flow hood. 
One gram samples from each feces collected was mixed 
with a sterilized phosphate buffered saline solution (PBS; 
137 mM NaCl, 2.7 mM KCl, 4.3 mM  Na2HPO4, 1.47 mM 
 KH2PO4, pH 7.4) [26]. After serial dilution, the suspen-
sion of each sample was plated on Lactobacillus Selection 
(LBS) (Difco) agar or transgalctosylated oligiosaccharide 
(TOS-MUP) (MB cell) agar and incubated under anaero-
bic conditions at 37  °C for 48  h for LAB isolation. LBS 
[27, 28] and TOS-MUP [29, 30] were used to screen Lac-
tobacillus and Bifidobacterium spp. from fecal samples, 
respectively.
One hundred fifty-six morphologically different 
microbial colonies were randomly collected and the 
selected colonies were Gram stained and morphologi-
cally evaluated using an optical microscope. The iso-
lated LAB strains were then cultured in modified MRS 
media according to our previous studies [9, 26, 31, 32]. 
In brief, all 156 LAB samples were inoculated and cul-
tured in seven types of modified MRS agar media with 
different carbon sources [10% (w/v) of glucose (Sigma), 
sucrose (Sigma), galactose (Sigma), lactose (Difco), fruc-
tose (Sigma), raffinose (Sigma) and maltose (Sigma)] and 
commercially available MRS media (1248 total samples).
According to Ruas-Madiedo and De Los Reyes-Gavilán 
[33], mucinous strands can be observed visually when 
sterilized inoculation loop are contacted with microbial 
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colonies that produce EPS as a metabolite. Therefore, we 
conducted an initial screening using a sterilized inocula-
tion loop or sterilized toothpicks to screen for EPS pro-
duction candidates. From the 1248 samples, the 10 most 
mucoid and slimy colonies and/or media conditions were 
selected for further study. 16S rRNA gene sequencing 
was performed to accurately identify these 10 strains at 
the molecular level.
Phylogenetic analysis
The selected microbial isolates were then subjected to 
phylogenetic analysis. DNA from each isolate was iso-
lated, amplified by PCR, and the 16S rRNA genes in 
the PCR products were sequenced. The PCR prim-
ers used were 27F (5′-AGA GTT TGATCMTGG CTC 
AG-3′)/1492R (5′-TAC GGY TAC CTT GTT ACG ACTT-
3′) and the 16 s rRNA sequencing primer was 785F (5′-
GGA TTA GAT ACC CTG GTA -3′)/907R (5′-CCG TCA 
ATTCMTTT RAG TTT-3′). The PCR sequencing step 
was executed by Macrogen, Inc. (Seoul, Korea), and the 
full sequence of 16S rRNA gene was aligned using the 
NCBI database, to the species level [34].
Analysis of EPS production properties of 10 LAB strains
The level of EPS production of 10 LAB strains cultivated 
in modified MRS broth containing 10% (w/v) sucrose 
instead of glucose was enumerated and compared using 
our previously published protocol with slight modifica-
tions [9, 26, 31, 32]. Specifically, cultured bacteria was 
boiled for 15 min and treated with 17% (v/v) 85% trichlo-
roacetic acid (TCA) (Sigma) 2 h after cell cultivation for 
24  h at 37  °C. LAB pellets were separated from culture 
media via centrifugation at 18,000×g for 25 min [35]. A 
5  ml aliquot of the supernatant was mixed with 25  ml 
of 95% ethanol (− 20 °C), and incubated at 4 °C for 16 h. 
The precipitated EPS was centrifuged at 18,000×g for 
20  min, and the supernatant was discarded. Crude EPS 
precipitant was collected and mixed with 5 ml of water. 
Water and crude EPS mixture was dialyzed using a com-
mercially available dialysis bag (12 to 14  kDa) and DI 
water at 4  °C for 48  h. The EPS sample inside each bag 
was collected and dried in a Speed Vacuum Concentra-
tor (ScanSpeed 40, SCANVAC; LaboGene) at 2000 rpm 
and 35 °C for 24 h. The EPSs in the media supernatants 
were then quantified by the phenol–sulfuric acid method 
in a microplate format using glucose as the reference 
standard [35]. EPS yields ranged from 0.12 ± 0.04 to 
59.99 ± 0.91 g/l. The highest EPS-producing LAB strains 
were selected for further analysis.
Structural analysis
The monosaccharide composition of EPS was ana-
lyzed after hydrolysis. Hydrolysis of EPS (10  mg) was 
performed with 2 ml of 2 M Trifluoroacetic acid (TFA) in 
a sealed tube at 110 °C for 6 h, and the TFA was removed 
by speed vacuum. The dried hydrolyzed samples were 
dissolved in distilled water (1 ml) and analyzed by HPLC 
(Thermo Fisher Scientific) [36]. The HPLC system con-
sisted of an Ultimate 3000 pump with an auto sampler 
and Shodex RI-101 (Shodex, Japan) detector. Sugars were 
analyzed by sugar-pak (Waters, 300*6.5  mm, USA) col-
umn maintained at 70  °C. Ten microliter samples were 
injected and eluted with triple distilled water at a flow 
rate of 0.5  ml/min. GPC and NMR analyses of the EPS 
produced was performed by the National Instrumenta-
tion Center for Environmental Management (NICEM) 
at Seoul National University Molar mass was determined 
by GPC [Thermo Dionex HPLC, Ultimate 3000 RI Sys-
tem (Thermo Fisher Scientific)]. A calibration curve was 
established with Pullulan standards of Mw 0.342, 10, 113, 
393, 805 kDa dissolved in water containing 0.1 M sodium 
azide  (NaN3). Three columns, Waters Ultrahydrogel 
120, Waters Ultrahydrogel 500 and Waters Ultrahydro-
gel 1000, with respective exclusion volumes of 5 × 103 
and 1 × 106 Da, were connected in series. The injected 
sample volume was 50 μl and the mobile phase was the 
same sodium azide buffer used to dissolve the sample, 
flowing at 1  ml/min at a temperature of 40  °C. NMR 
analysis was conducted using a High Resolution NMR 
Spectrometer (AVANCE 600, Bruker, Germany). Briefly, 
W. confusa VP30 was cultured in mMRS broth with 10% 
(w/v) of sucrose for 24 h anaerobically. The collected EPS 
was purified in the manner previously mentioned. 10 mg 
samples of purified EPS were dissolved in 1  ml of D2O 
and the process of 1H NMR, 13C NMR and 2D NMR was 
heteronuclear single-quantum coherence (HSQC), and 
Heteronuclear Multiple Bond Correlation (HMBC), at 
600 MHz at 25 °C.
Safety evaluations of W. confusa VP30
A safety assessment of W. confusa VP30 via ammonia 
production, hemolysis of blood cells and antimicrobial 
susceptibility analysis was conducted according to previ-
ously reported methods [25]. To evaluate the concentra-
tion of secreted ammonia, W. confusa VP30 was cultured 
in Brain Heart infusion (BD Bacto™BHI, LOT 8114937), 
and the cell-free broth supernatants were recovered after 
centrifugation at 10,000×g at 4  °C for 30  min. The BHI 
was adjusted to pH 7 using 1 N NaOH before cell inoc-
ulation. As previously mentioned, two types of chemi-
cal reagents were prepared. The 1st reagent consisted of 
1  g phenol and 0.005  g sodium nitroferricyanide dehy-
drate  (Na2[Fe(CN)5NO]·2H2O) dissolved in 100  ml DI 
water, and the 2nd reagent consisted of 500  mg NaOH 
and 0.04 g NaClO dissolved in 100 ml DI water. Aliquots 
(100 μl) of Solutions 1 and 2 were added to  Corning® 96 
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well plates (Costar # 3595, Corning, NY, USA) with 10 μl 
of the cell-free broth supernatants of W. confusa VP30. 
An ammonia solution (Junsei Chemical, Japan) was used 
as a control solution. The 96 well plates were incubated in 
25 °C for 1 h, and spectroscopy analysis was conducted at 
625 nm. Cell-free BHI broth was used as a negative con-
trol and the ammonia concentration was assessed using a 
standard curve. Three replications of this test were con-
ducted for statistical analysis of ammonia production 
from W. confusa VP30.
To evaluate microbial hemolytic properties, W. con-
fusa VP30 was anaerobically cultured in BHI agar sup-
plemented with 1.5% agar, 10% of sucrose and 5% horse 
blood at 37 °C for 2 days. Listeria ivanovii subsp. ivanovii 
ATCC 19119, a positive control for hemolysis, was aero-
bically cultivated in BHI agar at 37 °C for 2 days. Accord-
ing to our previous protocol [25], the plate was then 
observed for the presence of microbial hemolysis by 
holding the plate to a light source and looking through 
both sides of the plate. Strains showing blood lysis (trans-
parent region) around the colony were classified as 
microorganisms having hemolytic (β-hemolytic) charac-
teristics. Strains that produced green-hued zones around 
the colonies (α-hemolysis) or no hemolysis on the blood 
plates (γ-hemolysis) were considered non-hemolytic.
Minimum inhibitory concentration (MIC) tests 
were conducted to evaluate antimicrobial suscepti-
bility [25]. Sixteen antimicrobial agents were used: 
ampicillin sodium salt (Sigma, Lot# BCBW1243), car-
benicillin disodium salt (Sigma, Lot# 126M4775V), 
chloramphenicol (Sigma, Lot# SLBR8869V), clindamy-
cin hydrochloride (Sigma, Lot# 021M1533), dicloxa-
cillin sodium salt hydrate (Sigma, Lot# SZBD263XV), 
erythromycin (Sigma, Lot# WXBC4044V), gentamicin 
sulfate (Sigma, Lot# SLBP3082V), kanamycin sulfate 
(Sigma, Lot# 066M4019V), methicillin sodium salt 
(Sigma, Lot# BCBR6817V), metronidazole (Sigma, 
Lot# MKBZ3056V), neomycin sulfate (Sigma, Lot# 
LRAB3300), phosphomycin disodium salt (Sigma, Lot# 
096M4031V), polymyxin B sulfate salt (Sigma, Lot# 
126M4071V), spectinomycin sulphate (Sigma,Lot# 
LRAB3670), streptomycin sulfate salt (Sigma, Lot# 
SLBT8451), tetracycline (Sigma, Lot# 126M4769V), van-
comycin hydrochloride (sigma Lot# LRAB3620). Each 
of the antibiotic powders were dissolved and diluted in 
appropriate diluents and filter sterilized prior to addi-
tion to LAB susceptibility test medium (LSM) sup-
plemented with cysteine (LSM-Cys) broth medium, 
composed of 90% of Iso-Sensitest Broth (IST)(Mbcell 
Lot#P2745063MS, Seoul, Korea) and 10% of MRS(BD 
Difco™, Franklin Lakes, NJ, USA) broth medium. Serial 
dilutions of antimicrobial agents ranging from 1024 to 
0.0032 μg/ml were prepared. MIC values for all bacterial 
isolates were determined by the ISO 10932:2010 broth 
microdilution procedure [37]. The LSM-Cys broth 
medium supplemented with 0.03% (w/v) l-cysteine HCl 
containing antibiotics at different concentrations was 
used to prepare each well of a microwell plate. The inocu-
lum was adjusted to a turbidity equivalent to 0.16 to 0.2 
at 625  nm as measured by a spectrophotometer (Spec-
traMax 190 Microplate reader, Molecular Devices). The 
solution corresponded to approximately 3 × 108  cfu/ml. 
Each inoculum was added to a double strength LSM-Cys 
broth medium at a rate of 0.2%. A 50 μl diluted bacterial 
suspension was added to each well; no negative control 
well was employed. The microdilution plates were pre-
pared with a series of twofold dilutions of antibiotics. 
The microdilution plates were incubated at 37 °C for 48 h 
in an anaerobic (5%  CO2, 10%  H2 and 85%  N2) chamber. 
The MIC was defined as the lowest concentration of anti-
biotic giving a complete inhibition of visible growth in 
comparison to an antibiotic-free control well. The experi-
ments were replicated three times.
Statistical analysis
To evaluate EPS production levels, statistical analysis was 
performed with one-way ANOVA using SPSS 24.0 at a 
significance level of p < 0.05.
Results and discussion
Selection of high EPS‑producing cell strains
Multiple groups have screened and identified LAB capa-
ble of producing EPSs by cell and colony phenotypes in 
solid medium. This visual cell classification tool has been 
widely used for many years to identify EPS producing 
LAB from naturally occurring microbiota as a preselec-
tion process. This preselection process has the advantage 
of being able to screen multiple samples rapidly without 
special and expensive tools. However, this cell screen-
ing process is almost impossible to standardize because 
colony morphological differences are distinguished via 
subjective interpretation by the researcher [33]. In addi-
tion, some extracellular macromolecules and polymers 
from LAB might not show significant slime-forming 
properties and may thus potentially be misidentified as 
false negatives. According to Rühmann et  al. [38], one 
option to overcome this experimental issue is compari-
son of colony characteristics (shape, size, pigmentation, 
etc.) between induced and non-induced EPS production 
conditions. Since microbial culture conditions and the 
carbon source of the medium significantly affect EPS 
productivity and metabolite characteristics [39], effective 
substrate dependent EPS-producing LAB screening can 
be achieved by culturing selected cell strains on media 
supplemented with various carbon sources.
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In this work, a total of 156 morphologically differ-
ent human origin LAB cell colonies were screened 
from five young (1 to 6 years old) children’s fecal sam-
ples using selective media (i.e. LBS or TOS-MUP) as a 
prescreening step. All 156 LAB colonies were subcul-
tured in commercially available MRS, and pure micro-
bial cultures were obtained by streaking on agar plates. 
The pure LAB cultures were then cultivated in seven 
kinds of mMRS media containing one of seven sugars 
(glucose, sucrose, galactose, lactose, fructose, raffinose 
and maltose) or commercially available MRS plates. 
Stickiness was visually and qualitatively observed by 
touching the microbial colonies with a sterilized inocu-
lation loop or sterilized toothpicks. All 156 of the LAB 
colonies grown in sucrose showed the most sticky 
and viscous characteristics versus those grown with 
other carbohydrate sources. From these, 10 putative 
EPS-producing LAB candidates were chosen for fur-
ther study due to their mucoid, slimy, and string-form-
ing appearance. The 16s rRNA of each of these colonies 
was sequenced and the crude EPS was extracted and 
obtained by the protocol described by Mendi et al. [35]. 
Crude EPS solutions from these 10 LAB cultures were 
used to assess their total carbohydrate content via phe-
nol–sulfuric acid assay. Data comparison with NCBI 
database sequences for the variable region of the 16S 
rRNA gene to the species level identified eight out of 10 
putative EPS-producing LAB as belonging to the genus 
Lactobacillus and other two to Weissella and Bifido-
bacterium. The EPS production of each LAB strain is 
shown in Table 1. W. confusa VP30 (Fig. 1a) produced 
significantly more EPS than the other LAB strains with 
significant mucoid appearance (Fig.  1b). In the mMRS 
broth, the W. confusa VP30 produced 59.99 ± 0.91  g/l 
Table 1 Overall ranking of isolated strains based on EPS production in mMRS with 10% sucrose (w/v)
All microorganisms were anaerobically cultured in glucose-free basal MRS supplemented with 10% (w/v) sucrose at 37 °C for 24 h. One-way ANOVA followed by 
Duncan’s post hoc test statistical analyses were performed. EPS produced (g l−1) ± SE with different letters (where A > B > C) are significantly different at p < 0.05 (n = 3)
No. 16s rRNA Strain EPS produced, 
mean ± SD (g/l)
Host gender Host age
1 Weissella confusa VP30 59.99 ± 0.91A Male 5
2 Bifidobacterium longum subsp. longum JH628 0.29 ± 0.06B Male 1
3 Lactobacillus plantarum JH43A 0.28 ± 0.02B Female 4
4 Lactobacillus plantarum JH102 0.26 ± 0.07B Male 3
5 Lactobacillus fermentum JH43B 0.25 ± 0.11B Female 4
6 Lactobacillus paracasei JH907 0.23 ± 0.02B Female 3
7 Lactobacillus plantarum subsp. plantarum JH917 0.21 ± 0.04B Male 1
8 Lactobacillus plantarum JH639 0.21 ± 0.01B Female 4
9 Lactobacillus rhamnosus JH914 0.19 ± 0.04B Male 1
10 Lactobacillus paracasei JH124 0.12 ± 0.04C Female 4
Fig. 1 a Scanning electron microscope images of W. confusa VP30 isolated from a fecal sample from a 5 year old boy, and b Morphological aspects 
of EPS production by W. confusa VP30 grown under mMRS with 10% sucrose culture for 24 h
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of EPS, while the other identified LAB strains pro-
duced < 0.3 g/l of EPS. 
Weissella was originally classified as Leuconostoc or 
Lactobacillus. However, distinctive biochemical features 
in Leuconostoc or Lactobacillus were identified by Col-
lins et  al. and reclassified as Weissella in 1993 [40]. As 
a naturally occurring microbiota, Weissella has been 
widely engaged in spontaneous lactic acid fermentation 
and coolship alcoholic beverage fermentations [41], and 
various Weissella strains have recently attracted atten-
tion from academia due to their high EPS production 
ability. Unlike other studies that utilized food-origin bac-
teria, we isolated and used human-origin strains in this 
study. The major carbon sources that induce high EPS 
production varies depending on the microorganism [33]. 
Sugar transportation pathways, enzyme synthesis metab-
olism and sugar-nucleotide precursors can be regulated 
by catabolite repression [33]. In the screening step, all 
the carbon sources mentioned in the previous study were 
used. These results show that sucrose is the main carbon 
source for the production of EPS, which is consistent 
with previous studies [42, 43]. As shown in Table 2, Weis-
sella spp. have higher EPS production capacity than other 
LAB strains. However, the EPS production properties of 
W. confusa VP30 in this report are significantly higher 
than those previously reported.
Table 2 Various LAB culture conditions utilized for EPS quantitative analysis by other groups





W. confusa VP30 Young children 
feces
MRS + 10% 
sucrose
Dextran 3.8 × 106 60.0 ± 0.9 Phenol–sulfuric 
acid method
Glucose This work
W. cibaria WC4 Sourdough MRS + 10% 
sucrose 30 °C 
6 days
Glucan 1.1‑1.3 × 104 7.9 ± 0.1 Phenol–sulfuric 
method
– [46]
W. cibaria MG1 Sourdough MRS + 10% 
sucrose 30 °C 
48 h
Dextran 7.2 × 108 36.4 – – [78]
W. confusa 
KR780676
Idli batter MRS + 2% 
sucrose 30 °C 
48 h
Galactan ND 17.2 Dry weight – [88]
W. confusa NH02 Nham MRS + 4% 
sucrose 37 °C 
12 h
ND 1.13 × 106 18.08 – – [48]
W. hellenica 
SKkimchi3
Kimchi MRS + sucrose 
20 °C 48 h
Glucan 2.03 × 105 5.12 – – [49]
W. cibaria 27 Kimchi 60 g/l of sucrose 
22 °C and pH 
6.2 for 24 h





Soybean paste 5% sucrose 30 °C 
for 48 h




W. confusa – 80 g/l of sucrose – – 25.2 Freeze drying 
dry weight
[90]









Ogi 24.0 g/l sucrose, 
pH (7.00)





Plant 20 g/l of fruc‑
tose, 50 g/l of 
sucrose
Glucan 1.4 × 106 19.0 Polymer dry 
mass 42 °C 
48 h
[52]
W. cibaria Fermented 
sauropus 
androgynus
Sucrose Glucan – 6.4 Lyophilized dry 
weight
[45]
W. sp. PSMS4‑4 Plasom 5% White‑sugar 
30 °C
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Evaluation of EPS constituents
The carbohydrate composition of EPS isolated from 
W. confusa VP30 was consisted predominantly of glu-
cose.  The weight-average molecular weight (Mw) of the 
EPS was determined by GPC analysis with three col-
umns (i.e. Waters Ultrahydrogel 120, Waters Ultrahydro-
gel 500 and Waters Ultrahydrogel 1000), where a typical 
sharp symmetrical peak was observed (Fig.  2) [44, 45]. 
W. confusa VP30 produced 3.8 × 106 Da EPS which is 
significantly larger than those from other Weissella spp. 
(Table 2) [46–52].
The 1H NMR spectrum of the W. confusa VP30 pro-
duced EPS is shown in Fig. 3a. The peaks were distributed 
into two regions, upfield of 3.5–4.0  ppm and downfield 
of 4.9–5.3  ppm. This was in agreement with the 1H 
NMR spectrum of dextran where the proton signals at 
C-2, C-3, C-4, C-5, and C-6 were found in the range of 
Fig. 2 Elution profile and determination of molecular weight of 
W. confusa VP30 EPS by gel filtration on Thermo Dionex HPLC with 
Ultimate 3000 RI System. Pullulan of multiple molecular mass were 
used as the standard
Fig. 3 1D NMR spectrum of purified EPS from W. confusa VP30 in D2O: a 1H NMR (600 MHz); b 13C NMR (150 MHz). c HSQC spectrum; d HMBC 
spectrum
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3–4 ppm while C-1 was found in the 4–6 ppm region [47, 
53–55]. The chemical structure of EPS should be alpha 
as the chemical shift is 100.57/4.99 ppm for 13C/1H while 
5.3–5.7 ppm for 1H and 103–106 ppm for 13C belongs to 
beta form [47]. From the spectrum, two peaks of ano-
meric protons were observed. The high intensity peak at 
4.99 ppm was referred to as the anomeric proton of the 
α (1 → 6) linkages in the main chain [47, 56], whereas 
the low intensity peak at 5.33 ppm represented the ano-
meric proton of the α (1 → 3) branch linkages [56]. A 
ratio of 96.5:3.5 was obtained from the integration of the 
relative intensity of the signal at 4.99 and 5.33 ppm. This 
result suggests that the dextran was composed of 96.5% 
α (1 → 6) linkages in the main chain and 2.6% α (1 → 3) 
branch linkages. The 13C NMR spectrum revealed six 
peaks appearing between 68 and 100  ppm (Fig.  3b). In 
previous studies, anomeric carbon signals were gen-
erally found downfield, in the region of 95–105  ppm. 
The signals in 95–101  ppm were related to ɑ-anomeric 
carbons, and the signals in 101–105  ppm were due to 
β-anomeric carbons in 13C NMR spectra, which cor-
responded with the 1H NMR spectra [57]. Carbon sig-
nals at C-2, C-3, C-4, and C-5 were found in the range 
of 70–75 ppm, while C-6 was found in the upfield region 
at about 60 ppm [58]. Moreover, dextran branch linkage 
signals were found around 77–85 ppm [59]. In this study, 
the signal at 100.57  ppm was clearly due to the ano-
meric carbon C-1, while the signal at 68.39 ppm was due 
to C-6. This peak was also observed at a lower intensity 
compared to the other peaks since some parts of the α 
(1 → 6) linkages had been replaced by α (1 → 3) branches. 
However, the signal referring to branch linkages around 
77–85  ppm was absent due to the small amount of α 
(1 → 3) linkages. To assign the signals at 72.39, 73.04, 
74.26, and 76.26 ppm, the data from 2D NMR were also 
analyzed. HSQC(c) and HMBC(d), which provided the 
correlation between 1H and 13C direct bond and two 
bonds, respectively, were used to confirm the structure 
of the polysaccharide (Fig. 3c, d). From the HSQC spec-
trum, seven protons in the glucose residue were found 
to correlate. The correlation of 1H at 4.99 ppm and 13C 
at 100.57 ppm confirmed the presence of α (1 → 6) gly-
cosidic bond. Other assignments from the HSQC and 
HMBC analysis of each position are presented in Table 3. 
The NMR results are similar to dextran produced by W. 
confusa R003 [56] and this HSQC, and HMBC similari-
ties confirmed that the dextran was composed of glucose 
units linked with 96.5% α (1 → 6) glycosidic bonds and 
3.5% α (1 → 3) branches. This data is consistent with oth-
ers’ data and reconfirms the special chemical structure of 
Weissella EPS (dextran) which shows high linearity with 
long chains and low branching [56, 60]. The highly linear 
dextran from W. confusa VP30 could be used as a food 
modifier for thickening, viscosifying and also as a poten-
tial soluble fiber which can act as a prebiotic [61]. 
Safety evaluation
Multiple Weissella strains have been detected and 
screened from traditional fermented foods as naturally 
occurring microbiota. Specifically, W. viridescens, W. 
confusa and W. cibaria were extracted from fermented 
vegetables [62–64] (e.g. kimchi and sauerkraut); from 
fermented meat products [65, 66] (i.e. Italian fermented 
sausages and Greek dry salami), W. hellinica, W. para-
mesenteroides, W. viridescens, W. paramesenteroides, W. 
minor and W. halotolerans were isolated. W. hellenica, 
W. halotolerans and W. viridescens were identified from 
fermented dairy product [67–69] (e.g. Romanian, mozza-
rella and cheddar cheeses).
Many research groups are trying to identify the bio-
functional activities of Weissella spp. and practically 
apply them to food, feed, and/or cosmetic products as a 
starter cultures and/or additives [70–73]. Recently, Lee 
et al. [74] proposed two W. confusa spp. (i.e. W. confusa 
20 and 31) screened from human fecal samples as poten-
tial probiotic bacteria due to their high antibiotic sensi-
tivity and cell adhesion properties. W. kimchii PL9023 
was isolated from the vagina of a healthy premenopau-
sal woman and has been proposed as a potential probi-
otic bacteria due to its inhibitory effects on fungal and 
Table 3 Assignment of 1H/13C chemical shift of dextran from W. confusa VP30 correlated with dextran from Netsopa et al. 
[56]
Atom position 1 2 3 4 5 6
W. confusa R003 [56]
 1H 4.98 3.58 3.72 3.52 3.9 3.76/3.98
 13C 100.28 74.1 76.09 72.28 72.88 68.33
W. confusa VP30
 1H 4.99 3.59 3.72 3.54 3.91 3.77/3.99
 13C 100.57 74.26 76.26 72.39 73.04 68.39
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bacterial vagina infection by Candida albicans, Escheri-
chia coli, Staphylococcus aureus and Streptococcus 
agalactiae [75]. Fusco et  al. [76] reported six types of 
bacteriocin-producing Weissella spp. (i.e. W. parames-
enteroides, W. hellenica, and W. cibarian). Recently, Kang 
et al. [77] practically applied W. cibaria to chewing gum 
and evaluated cell survival rates with changed environ-
mental factors (e.g. temperature and additives). Zannini 
et al. [78] applied W. cibaria MG1 isolated from cereal to 
wort (beer substrate) production. Recently Abriouel et al. 
[79] published reviews of anti-viral, anti-tumoral, anti-
obesity, anti-inflammatory, and antioxidant activities of 
Weissella and suggested the possibility of their use as a 
starter culture.
Although the superior functionality and universality of 
the Weissella spp. in fermented foods is of interest within 
academia, several studies have also warned of the possi-
bility for side effects (e.g. hemolytic activity, production 
of toxic substances during ammonia metabolism, and 
antibiotic resistance by their host). Recently, Abriouel 
et  al. [79] conducted in silico gene expression analysis 
with several Weissella spp. and reported the presence 
of antibiotics (e.g. daunorubicin, fosfomycin, methicil-
lin and tetracycline) resistance, hemolysin gene in these 
microorganisms. Jung and Lee [80] evaluated the antibi-
otic resistance, hemolysis and biogenic amine production 
properties of 45 Weissella strains (i.e. W. cibaria [n = 33], 
W. confusa [n = 11] and W. paramesenteroides [n = 1]) 
isolated from kimchi for kimchi starter development. 
They reported that all Weissella strains (n = 45) showed 
significant antibiotic resistance against streptomycin 
when the disk diffusion test was applied. Specifically, 
54.5% of tested W. cibaria (n = 18) was resistant to gen-
tamicin, and 15.2% to penicillin G (n = 5). 8.5% of W. con-
fusa was resistant to gentamicin (n = 3). In their study, 
only one species of W. paramesenteroides (n = 1) was 
used, and this strain showed antibiotic resistance against 
gentamicin. In addition, some LAB are known to produce 
ammonia, which is generally regarded as a toxic sub-
stance produced by edible microorganisms via utilization 
of nitrogen sources during fermentation [81, 82]. There-
fore, safety evaluation is critically required for further 
industrial applications even though W. confusa VP30 has 
been isolated from the feces of healthy children.
Listeria ivanovii subsp. ivanovii ATCC 19119 and W. 
confusa VP30 were streaked on BHI with 1.5% agar and 
5% horse blood and incubated at 37  °C for 48  h. The 
microorganisms that produced clear and/or transpar-
ent zones around the cell colonies were classified as 
β-hemolytic. Microorganisms that did not generate any 
visual changes on the blood agar were regarded non 
hemolytic cell. Figure  4 shows significant transparent 
and clean zones around the β-hemolytic positive con-
trol Listeria ivanovii subsp. ivanovii ATCC 19119, due 
to the complete lysis of red blood cells on the media. 
Other strains belonging to the Weissella confusa spe-
cies have been reported as alpha- hemolytic [83]. How-
ever, W. confusa VP30 generated no clear or transparent 
zones on the blood agar around their microbial colonies, 
indicating that W. confusa VP30 is non-hemolytic (a.k.a. 
γ-hemolytic).
LAB’s ammonia production property can potentially 
be related to host gastrointestinal health. Some research-
ers have reported ammonia production properties of 
Fig. 4 a Comprehensive lysis of red blood cells was observed with clear zones around the Listeria ivanovii subsp. ivanovii ATCC 19119 (positive 
control). b W. confusa VP30 growth with no blood cell lysis on the blood agar. The hemolytic activity of each strain was assessed in triplicate
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Lactobacillus spp. [82, 84]. Therefore it is necessary to 
evaluate W. confusa VP30’s ammonia production capa-
bility and demonstrate its safety for further application 
in processed food production [25]. A colorimetric assay 
was used to assess the level of ammonia in the media 
after incubation. Enterobacter cloacae KCTC 2361, the 
positive control for ammonia production, produced 
11.5 ± 0.9 µg/ml of ammonia while W. confusa VP30 was 
negative.
Excessive use of antibiotics has been reported to con-
tribute to increasing numbers of pathogens having anti-
biotic resistance, which is considered a serious threat to 
the treatment of bacterial infection. Although many LAB 
are not commonly regarded as pathogenic bacteria, it is 
desirable that they be sensitive to commercially available 
antibiotics at low concentrations. To evaluate the anti-
microbial resistance properties of W. confusa VP30, we 
conducted MIC tests based on the International Organ-
ization for Standardization (ISO) standard protocol. 
Based on the MIC criteria for microorganisms used in 
food or feeds prescribed in EFSA [85], W. confusa VP30 
was found to have no significant resistance to gentamicin, 
kanamycin, streptomycin, tetracycline, clindamycin, 
ampicillin (< 4 µg/ml, Table 4). Although there are no ref-
erence concentration and/or guidelines for methicillin, 
dicloxacillin hydrate, polymyxin B sulfate, bacitracin, 
neomycin, carbenicillin and spectinomycin resistance, W. 
confusa VP30 was found to be sensitive to these antibi-
otics as well, with MIC values ranging from 1 to 32 μg/
ml. On the other hand, W. confusa VP30 was resistant to 
erythromycin and chloramphenicol. (MIC ranging from 
2 to 8  μg/ml). Compared with other W. confusa strains 
[86, 87], Lactobacillus plantarum ATCC 14917 [37] and 
Lactobacillus paracasei ATCC334 [37], W. confusa VP30 
have similar or lower MIC concentrations of gentamicin, 
kanamycin, tetracycline, clindamycin, ampicillin and 
erythromycin.
Conclusion
The objective of this work was to screen and charac-
terize high level EPS-producing LAB from healthy 
children’s feces for potential functional food applica-
tions. As a prescreening process, 156 LAB cell strains 
were screened and isolated using LAB selective media 
(i.e. LBS and TOS-MUP) and cultivated in eight differ-
ent modified MRS broths containing various sugars. 
When the 156 LAB strains were cultivated in media 
supplemented with sucrose as the major carbon source, 
the viscosity of microbial colonies was increased. The 
10 most mucoid and slimy colony-producing colonies 
Table 4 MIC distributions of  seventeen antibiotics for  W. confusa VP30 isolates from  a  child fecal sample determined 




















Gentamicin 1 ≤ 2 3 1 to 4 – 16
Kanamycin 4 – – 16 to 64 – 16
Vancomycin > 128 Resistant > 256 – – nr
Streptomycin 32 – – 8 to 12 – 64
Tetracycline 2 4 to 8 – 1 to 4 8 to 32 8
Clindamycin < 0.032 ≤ 0.5 0.06 0.06 to 0.25 0.5 to 4 1
Ampicillin 0.5 0.5 0.5 0.5 to 2 0.25 to 2 2
Erythromycin 2 ≤ 0.25 0.13 0.06 to 0.5 0.25 to 2 1
Methicillin 32 – – – – –
Dicloxacillin salt 
hydrate
8 – – – – –
Polymycin B sulfate salt 32 – – – – –
Bacitracin 1 – – – – –
Methronidazole 512 > 256 – – –
Phosphomycin diso‑
dium salt
> 1024 – – – –
Neomycin 2 – – – – –
Carbenicillin 2 – – – – –
Chloramphenicol 8 8 – 2 to 8 4 to 16 4
Spectinomycin 32 – – – – –
Page 11 of 13Jin et al. Microb Cell Fact          (2019) 18:110 
were selected based on their solid agar media pheno-
types as EPS positive strains. 16S rRNA gene sequenc-
ing analysis showed that these high EPS-producing cell 
strains were members of Weissella confusa, Bifidobac-
terium longum, Lactobacillus plantarum, Lactobacillus 
fermentum, Lactobacillus paracasei and Lactobacillus 
rhamnosus genus and species. Among them, W. con-
fusa VP30 showed significantly higher EPS productiv-
ity compared to the other cell strains and was selected 
for further testing. The maximum EPS production by 
W. confusa VP30 was 59.99 ± 0.91 g/l. Structural analy-
sis of the released EPS fraction by NMR revealed that 
W. confusa VP30 can produce dextran of 3.8 × 106 Da, 
containing glucose units linked with 96.5% α (1 → 6) 
glycosidic bonds and 3.5% α (1 → 3) branches. Safety 
assessment of W. confusa VP30 was accomplished via 
ammonia production, hemolysis of blood cells and anti-
biotic resistance analyses. There is no evidence that this 
LAB strain is unsafe for human consumption, based on 
our results. Considering the active EPS producing capa-
bility and safety of W. confusa VP30, this microbial cell 
strain can be considered for use by the food industry.
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